Gluvilda M +500 Tablet SR
Gluvilda M +500 Tablet SR
Metformin (500mg) + Vildagliptin (50mg)
Cheaper alternative availability
Already at the Best Price
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
About This Medicine
Product description & overview
Gluvilda M +500 Tablet SR is a combination oral antihyperglycemic agent containing Metformin 500 mg and Vildagliptin 50 mg, formulated for sustained release to enhance glycemic control in patients with type 2 diabetes mellitus. Metformin, a biguanide, primarily acts by decreasing hepatic glucose production and improving insulin sensitivity in peripheral tissues, thereby reducing fasting and postprandial blood glucose levels. Vildagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, enhances the incretin system by preventing the degradation of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), resulting in increased insulin secretion and decreased glucagon release in a glucose-dependent manner. The combination of these two agents targets multiple pathophysiological defects of type 2 diabetes, providing improved glycemic control compared to monotherapy. Gluvilda M +500 Tablet SR is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes inadequately controlled on metformin alone or in combination with other antidiabetic agents. It should be used with caution in patients with renal or hepatic impairment, and regular monitoring of renal function is recommended. Common adverse effects include gastrointestinal disturbances and mild hypoglycemia.
Active composition
Metformin 500 mg
+1 more active ingredient
About Metformin
Metformin is an oral antihyperglycemic agent used to manage type 2 diabetes mellitus. It works by decreasing glucose production in the liver and improving insulin sensitivity. Metformin is effective in controlling blood sugar levels and preventing diabetes-related complications. In summary, Metformin is vital for managing type 2 diabetes.
How It Works
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
All Active Ingredients
Vildagliptin
Vildagliptin inhibits DPP-4, leading to increased levels of incretin hormones, which stimulate insulin secretion and decrease glucagon levels.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
Gluvilda M +500 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Pregnancy
Gluvilda M +500 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Driving
Gluvilda M +500 Tablet SR should be used with caution in patients with kidney disease. Dose adjustment of Gluvilda M +500 Tablet SR may be needed. Please consult your doctor.
Exercise Caution
Breastfeeding
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Consult Doctor
Kidney
Gluvilda M +500 Tablet SR is probably unsafe to use in patients with liver disease and should be avoided. Please consult your doctor.
Regular Checkup
Customer Reviews
0 reviews for Gluvilda M +500 Tablet SR
